Cencora, Inc. NYQ · COR
Price alert —
Sign in to get a one-time email the moment COR crosses your price. Free accounts included.
Sign in / create a free accountCencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S.
COR last traded at $307.90, down 0.0% on the day; that's in the middle part of its 52-week range ($244.82–$376.92). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.
The next scheduled earnings report (2026-08-05) is the biggest known catalyst on the calendar, and after a strong run, watch whether the price can hold its gains on quieter days.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
KC2 upper, +1.54 ATR from EMA21 — no notable pattern
- · Stochastic bull cross
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
- · KC2 upper stretch — standard mean-reversion tier
- · RSI hook from overbought (64)
- · Aligned with weak downtrend
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
On the latest daily bar, momentum sits mid-range (RSI 64), the trend is strong (ADX 28), and volume is about normal (1.4×). On the business side, revenue is growing 4% year over year and the business keeps about -0 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
The model's verdict is “Unknown” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ Positive retained earnings
- ⚠ Debt exceeds cash
- ⚠ Quick ratio 0.47 (fragile)
- ⚠ Debt/equity 49.63 (fragile)
COR is a $59.9 billion company, priced at 24× last year's earnings, and it moves more calmly than the market (beta 0.6).
Options idea
See more →Earnings
See more →- Last reported
- 2026-05-06
- EPS (act / est)
- 4.75 / 4.73
- Surprise
- +0.5%
- Next report
- 2026-08-05
About
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail phar…